La chaîne d'options affiche les données clés des options sur actions de Empro Group à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Empro Group..

Empro Group (NASDAQ:EMPG) Stock, Chaîne d'Options

Empro Group Inc operates in the Health and Beauty industry, focusing on enhancing well-being and confidence through a combination of skincare, cosmetics, healthcare products, and embroidery services. The company derives majority of its revenue from health care business segment involves trading and wholesaling of medical masks, COVID-19 test kits and related products.

<h3>Companies Reporting Before The Bell</h3>
• Prologis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLD#NYSE">PLD</a>) is projected to report quarterly earnings at $1.41 per share on revenue of $2.02 billion. 
• ASML Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) is likely to report quarterly earnings at $5.94 per share on revenue of $8.55 billion. 
• M&amp;T Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTB#NYSE">MTB</a>) is projected to report quarterly earnings at $4.02 per share on revenue of $2.39 billion. 
• Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) is likely to report quarterly earnings at $2.67 per share on revenue of $22.83 billion. 
• Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) is likely to report quarterly earnings at $0.87 per share on revenue of $26.70 billion. 
• Goldman Sachs Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) is likely to report quarterly earnings at $9.58 per share on revenue of $13.52 billion. 
• First Horizon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FHN#NYSE">FHN</a>) is likely to report quarterly earnings at $0.41 per share on revenue of $830.86 million. 
• Marten Transport (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRTN#NASDAQ">MRTN</a>) is projected to report quarterly earnings at $0.09 per share on revenue of $230.26 million. 
• PNC Financial Services Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNC#NYSE">PNC</a>) is projected to report quarterly earnings at $3.54 per share on revenue of $5.61 billion. 
• Progressive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PGR#NYSE">PGR</a>) is projected to report quarterly earnings at $4.29 per share on revenue of $20.82 billion. 
• Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) is expected to report quarterly earnings at $1.98 per share on revenue of $15.99 billion. 
• Commerce Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBSH#NASDAQ">CBSH</a>) is estimated to report quarterly earnings at $1.03 per share on revenue of $433.27 million. 
<h3>Companies Reporting After The Bell</h3>
• SL Green Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLG#NYSE">SLG</a>) is likely to report quarterly earnings at $1.37 per share on revenue of $162.42 million. 
• Rexford Industrial Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REXR#NYSE">REXR</a>) is estimated to report quarterly earnings at $0.58 per share on revenue of $248.92 million. 
• First Industrial Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FR#NYSE">FR</a>) is likely to report quarterly earnings at $0.72 per share on revenue of $176.41 million. 
• United Airlines Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) is likely to report quarterly earnings at $3.87 per share on revenue of $15.34 billion. 
• Triumph Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TFIN#NASDAQ">TFIN</a>) is estimated to report quarterly earnings at $0.06 per share on revenue of $105.08 million. 
• South Plains Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPFI#NASDAQ">SPFI</a>) is projected to report quarterly earnings at $0.77 per share on revenue of $51.89 million. 
• Synovus Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNV#NYSE">SNV</a>) is likely to report quarterly earnings at $1.25 per share on revenue of $585.13 million. 
• Monarch Casino &amp; Resort (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCRI#NASDAQ">MCRI</a>) is likely to report quarterly earnings at $1.19 per share on revenue of $130.00 million. 
• Kinder Morgan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMI#NYSE">KMI</a>) is projected to report quarterly earnings at $0.27 per share on revenue of $3.80 billion. 
• Home BancShares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HOMB#NYSE">HOMB</a>) is projected to report quarterly earnings at $0.57 per share on revenue of $261.79 million. 
• Great Southern Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSBC#NASDAQ">GSBC</a>) is likely to report quarterly earnings at $1.35 per share on revenue of $56.04 million. 
• Banner (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BANR#NASDAQ">BANR</a>) is projected to report quarterly earnings at $1.31 per share on revenue of $165.66 million. 
• AAR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIR#NYSE">AIR</a>) is projected to report quarterly earnings at $1.00 per share on revenue of $693.89 million. 
• Alcoa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>) is expected to report quarterly earnings at $0.43 per share on revenue of $2.94 billion. 
• Martin Midstream Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMLP#NASDAQ">MMLP</a>) is likely to report earnings for its second quarter. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

ASML

BANR

CBSH

GSBC

HOMB

MCRI

MMLP

MRTN

REXR

SPFI

TFIN

Earnings Scheduled For July 16, 2025

News

Tech

NVDA

Nvidia CEO Jensen Huang, Speaking At The International Supply Chain Expo in Beijing Said The U.S. Government Is Processing The Licensing For The H20 Orders From Chinese Customers Now

Willis, a WTW business, (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>), today announced a new collaboration with the University of East Anglia (UEA) to deepen understanding of global wildfire risk. With wildfires now rivalling the losses caused by other perils such as hurricanes, this partnership aims to deliver credible scientific insight that helps insurers and reinsurers keep pace with a rapidly changing risk landscape.
Wildfires have intensified in recent years, becoming larger, more destructive, and increasingly unpredictable. Shifting climate conditions are expanding fire-prone areas beyond traditional hotspots and triggering more intense and destructive fires, while urban growth and rising property values are amplifying the potential for catastrophic loss. From insured losses amounting to US$1.5 billion during Australia's Black Summer bushfires in 2019-20 to the US$40 billion in damage caused by this year's Palisades and Eaton fires in Los Angeles, wildfires are no longer a secondary peril.
This collaboration will focus on helping the insurance sector understand the shifting nature of wildfire risk, including changes in fire frequency, intensity, geography, and the growing threat of urban conflagrations. By combining Willis' catastrophe risk expertise with the leading climate and fire science of Dr. Matthew Jones at UEA, the partnership will support clients in anticipating wildfire-related losses and responding with more informed risk strategies.

WTW Partners With University of East Anglia To Study Growing Global Wildfire Risk

Personal finance author and radio host Dave Ramsey has shared his views on investment strategies, advising against bonds and single stocks. He emphasized his preference for mutual funds as a safer and more lucrative option.
What Happened: Ramsey, in response to a question from a novice investor, Joseph, about his thoughts on bonds and other investment advice, dismissed the idea of bonds being a safer investment than stocks.
He pointed out that the bond market is almost as volatile as the stock market due to fluctuating interest rates, with less promising returns, as per a Ramsey Solutions report titled &#8220;Dave Says: Be the Tortoise,&#8221; which was posted <a href="https://www.ramseysolutions.com/company/newsroom/ramsey-syndication/Dave-Says--Be-the-Tortoise">on</a> Monday.
Ramsey, who has a substantial investment in the market, revealed that he does not own any bonds or single stocks due to the associated risks. Instead, he prefers mutual funds, which typically consist of 90-200 different stocks.
See Also: <a href="https://benzinga.com/crypto/cryptocurrency/25/07/46429234/bitcoin-xrp-dogecoin-dip-but-ethereum-outperforms-after-inflation-report" target="_blank" rel="noopener">Bitcoin, XRP, Dogecoin Dip But Ethereum Outperforms After Inflation Report</a>
He also highlighted the benefits of Health Savings Account (HSA) investments in mutual funds, emphasizing his long-term, buy-and-hold approach to investing.
He concluded by advising Joseph to adopt a slow and steady approach to investing, akin to the tortoise in the fable &#8220;The Tortoise and the Hare,&#8221; as this method consistently yields results.
&#8220;Keep this in the back of your mind, Joseph. If all your broke friends are impressed with your investing, chances are you're doing it wrong. Or at the very least, you could be doing a whole lot better,&#8221; Ramsey said.
Why It Matters: Ramsey&#8217;s investment advice aligns with the strategies of other prominent figures in the finance world. For instance, the legendary investor Warren Buffett has often emphasized the importance of long-term investment in <a href="https://www.benzinga.com/general/education/25/05/45602754/warren-buffett-investment-success-3-simple-rules-to-copy-oracle-of-omaha">diversified stocks</a> for consistent returns. 
Similarly, former White House communications director Anthony Scaramucci once experienced the power of <a href="https://www.benzinga.com/tech/25/04/45057119/anthony-scaramucci-once-purchased-1200-worth-of-microsoft-stock-for-his-son-in-1992-and-then-forgot-about-it-three-decades-later-it-quietly-turned-into-a-small-fortune-that-he-didn't-know-he-owned">long-term investing</a> when his forgotten investment in Microsoft Corporation stock turned into a substantial sum.
Ramsey&#8217;s advice also resonates with his previous statements on wealth-building. In a <a href="https://www.benzinga.com/25/02/43631283/its-your-own-fault-if-youre-25-and-dont-end-up-a-millionaire-warns-dave-ramsey-explains-how-even-40-year-olds-can-hit-1-million-by-60">social media post</a> in January 2025, he emphasized the simplicity of becoming a millionaire through consistent investing and reducing wasteful spending, even for those who start later in life.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://benzinga.com/crypto/cryptocurrency/25/07/46394828/bitcoin-eth-xrp-solana-are-in-for-a-long-and-exhausting-bull-market-bernstein-predicts" target="_blank" rel="noopener">Bitcoin, ETH, XRP, Solana Are In For A &#8216;Long And Exhausting Bull Market,&#8217; Bernstein Predicts</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Mutual Funds

Personal Finance

Dave Ramsey Rejects Bonds And Stocks, Calls Mutual Funds Safer Bet: 'Be The Tortoise'

President Donald Trump has credited First Lady Melania Trump for influencing his tougher stance on the Russia-Ukraine conflict.
What Happened: During a meeting with NATO Secretary General Mark Rutte in the White House on Tuesday, Trump acknowledged Melania&#8217;s role in challenging his optimistic perspective on the Russia-Ukraine war. Trump shared instances where Melania had expressed skepticism after his phone calls with Putin. 
&#8220;I&nbsp;go home, I tell the&nbsp;first lady: I spoke with&nbsp;Vladimir today. We had a&nbsp;wonderful conversation. She said: Really?&nbsp;Another city was just hit,&#8221; Trump said.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="NEW: Trump reveals Melania&#039;s role in dealing with Putin" width="500" height="281" src="https://www.youtube.com/embed/SpvjANui62s?start=78&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
While addressing the press at another instance, Trump reiterated, &#8220;There&#8217;s times I&#8217;d get home. I&#8217;d say, &#8216;First lady, I had the most wonderful talk with Vladimir. I think we&#8217;re finished.&#8217; And then I&#8217;ll turn on the television, or she&#8217;ll say to me one time, ‘Wow, that's strange because they just bombed a nursing home,'&#8221;
Trump later described her, saying, &#8220;She&#8217;s very smart&#8230;she&#8217;s very neutral. She&#8217;d like to see people stop dying.&#8221;
This revelation sparked a wave of support for Melania on social media in Ukraine, with one user even dubbing her &#8220;Agent Melania Trumpenko,&#8221; <a href="https://www.theguardian.com/us-news/2025/jul/15/ukrainians-hail-melania-trump-for-challenging-husbands-faith-in-putin">reported </a>The Guardian. Ukrainians expressed their appreciation for Melania&#8217;s influence, particularly after the U.S. announced it would provide Patriot air defense systems to Ukraine. 
Notably, Melania Trump, who was born in Slovenia, has consistently voiced support for Ukraine since Russia's full-scale invasion in 2022, describing the suffering of innocent people as "heartbreaking and horrific."
SEE ALSO:&nbsp;<a href="https://benzinga.com/crypto/cryptocurrency/25/07/46422927/bonk-rallies-30-in-1-week-should-dogecoin-shiba-inu-be-afraid" target="_blank" rel="noreferrer noopener">Bonk Rallies 30% In 1 Week: Should Dogecoin, Shiba Inu Be Afraid? &#8211; Benzinga</a>
Why It Matters: Trump&#8217;s acknowledgment of Melania&#8217;s influence comes in the wake of his recent decisions regarding the Russia-Ukraine conflict. On Sunday, Trump announced plans to&nbsp;supply Ukraine with <a href="https://www.benzinga.com/news/25/07/46384536/trump-says-us-will-supply-ukraine-with-patriot-missiles-putin-really-surprised-a-lot-of-people-he-talks-nice-and-bombs-everybody-in-the-evening">Patriot missiles&nbsp;</a>as a countermeasure against Putin&#8217;s ongoing resistance to ceasefire negotiations.
However, Trump&#8217;s strategy has also drawn criticism. On Monday, leading economist&nbsp;Justin Wolfers&nbsp;criticized Trump&#8217;s proposed&nbsp;<a href="https://www.benzinga.com/markets/economic-data/25/07/46407695/trumps-100-tariff-threat-on-almost-nothing-trade-with-russia-a-prescription-for-how-to-sound-tough-but-do-nothing-says-economist">100% tariff threat </a>on Russia&nbsp;if a peace deal is not reached within 50 days. Wolfers argued that this threat, given the existing U.S. sanctions on Russia, would have little impact on Moscow.
Despite the criticism, Trump <a href="https://www.benzinga.com/news/politics/25/07/46408496/trump-says-talk-doesnt-mean-anything-when-it-comes-to-putin-announces-plan-to-help-ukraine">remained resolute</a> in his approach, stating that&nbsp;&#8220;talk doesn&#8217;t mean anything&#8221;&nbsp;when it comes to Putin and announcing plans to help Ukraine by providing advanced U.S. weapons to European allies for distribution to Kyiv.
READ MORE: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/economic-data/25/07/46364387/us-500-tariff-on-russia-can-rattle-energy-stocks-and-have-major-negative-implications-on-global-economy-says-craig-shapiro">US 500% Tariff On Russia Can Rattle Energy Stocks And Have &#8216;Major Negative Implications&#8217; On Global Economy, Says Craig Shapiro </a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Trump Reveals Melania's Role In Toughening His Stance On Vladimir Putin: 'I Go Home, I Tell The First Lady...'

Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) plans on introducing more affordable EVs and electrified vehicles in its lineup as President Donald Trump curbs EV-related incentives in the U.S.
Check out the current price of <a href="https://benzinga.com/quote/f">F</a> stock here.
What Happened: "When it comes to affordability, we have to compete. Not just in our industry but on a global scale as well." Bob Holycross, Ford's chief sustainability, environment and safety officer, told Bloomberg <a href="https://www.bloomberg.com/news/articles/2025-07-15/ford-promises-more-affordable-ev-models?srnd=phx-industries-transportation">on</a> Tuesday.
Holycross said that if Ford needed a more significant majority in the EV sector, the company would need to introduce more affordable EVs and electrified vehicles to its range.
He also shared that Ford is planning on introducing more Hybrid models in its lineup. Engineers at Ford are also working towards testing range-extended EVs, the report suggested. Range-extended EVs are electric vehicles that have a gasoline unit built in solely to help boost driveable range.
Ford's cheapest EV retails for $38,000, which is 22% more affordable than the standard price customers pay to buy cars in the U.S., the report suggests.
Why It Matters: The news comes following earlier reports that the Detroit-based automaker was working on an <a href="https://www.benzinga.com/markets/tech/25/06/46020713/ford-says-upcoming-budget-ev-platform-will-rival-chinese-ev-prices-report">affordable EV platform</a> to compete against the Chinese rivals.
However, as Trump axed the <a href="https://www.benzinga.com/markets/tech/25/07/46289556/trumps-tax-bill-axes-the-7500-ev-credit-heres-how-you-can-still-claim-it">$7,500 Federal EV Credit</a> in the U.S., Ford's F-150 Lightning EV pickup truck will become more expensive after the <a href="https://www.benzinga.com/markets/tech/25/07/46270052/as-trumps-big-beautiful-bill-is-signed-into-law-these-evs-from-tesla-gm-and-ford-will-become-more-expensive">September 30 deadline</a>.
Ford sales also <a href="https://www.benzinga.com/markets/tech/25/07/46213625/ford-sales-surge-14-2-in-q2-beating-market-estimates-but-ev-sales-decline-31">surged 14.2%</a> in Q2, which beat market expectations as the company said it sold 612,095 units in the second quarter of the year. The company also announced it would go ahead with its <a href="https://www.benzinga.com/markets/tech/25/06/46074112/ford-to-proceed-with-3-billion-battery-plant-despite-potential-tax-incentive-loss-under-trumps-budget-plan-we-stick-behind-our-investments">plans to invest $3B</a> in the company's Michigan battery plant despite potential tax incentive loss.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="202" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/16024526/F-JUL-16-2025-1024x202.jpg" alt="" class="wp-image-987183" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/16024526/F-JUL-16-2025-1024x202.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/16024526/F-JUL-16-2025-300x59.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/16024526/F-JUL-16-2025-768x151.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/16024526/F-JUL-16-2025-1536x303.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/16024526/F-JUL-16-2025.jpg 1563w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Ford offers Satisfactory Momentum and Growth, while scoring well on the Growth and Value metrics. For more such insights, sign up for <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Benzinga Edge Stock Rankings</a> today!
Check out more of Benzinga's Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46434613/elon-musks-tesla-could-face-stricter-oversight-as-trumps-nhtsa-pick-targets-autonomous-driving-cannot-sit-back">Elon Musk&#8217;s Tesla Could Face Stricter Oversight As Trump&#8217;s NHTSA Pick Targets Autonomous Driving: &#8216;Cannot Sit Back&#8217;</a></li>
</ul>
Photo courtesy: Tada Images / Shutterstock.com

Ford Responds To Trump's EV Policy Shift With Push For Affordable Electric Models

Polyrizon Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) saw a dip in its stock value during after-hours trading on Wednesday.
What Happened: The after-hours price of Polyrizon&#8217;s stock was $0.92, marking a 12.02% dip from the previous day&#8217;s closing price of $1.04. This follows a regular trading session surge of 52.47%.
See Also: <a href="https://benzinga.com/markets/25/07/46383911/virginia-homeowner-says-neighbor-illegally-cut-down-89-year-old-oak-tree-on-his-land-then-had-the-ne">Virginia Homeowner Says Neighbor Illegally Cut Down 89-Year-Old Oak Tree On His Land — Then Had the Nerve To &#8216;Demand&#8217; He Pay Half The $2k Bill &#8211; Benzinga</a>
The surge in the stock value on Tuesday follows the company&#8217;s successful appeal to the NASDAQ panel, which enabled it to retain its listing on the exchange. The appeal was crucial for the biotech company, as it faced the risk of being delisted due to non-compliance with Nasdaq&#8217;s listing rules.
Why It Matters: Polyrizon&#8217;s stock value has been on a rollercoaster ride recently. Earlier in July, the company&#8217;s stock value also <a href="https://www.benzinga.com/insights/movers/25/07/46425317/12-health-care-stocks-moving-in-tuesdays-intraday-session">experienced a significant increase</a> after the news of its continued Nasdaq listing. This was after a hearing panel confirmed the company&#8217;s compliance with the exchange&#8217;s listing rules.
These developments come on the heels of Polyrizon&#8217;s announcement of <a href="https://www.benzinga.com/news/25/06/45901285/polyrizon-announces-preclinical-results-from-study-evaluating-its-trap-target-platform-showing-formu">successful preclinical results</a> from a study evaluating its Trap &amp; Target platform. The study showed that the platform&#8217;s formulation achieved targeted deposition in the upper regions of the nasal cavity.
Price Action: PLRZ surged 52.47% to close at $1.04 on July 16, according to <a href="https://www.benzinga.com/quote/plrz">Benzinga Pro</a> data.
Benzinga&#8217;s Edge Stock Rankings indicate Polyrizon stocks have negative trends across all time frames. Know how the stock fares on <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-4/#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">other parameters here</a>.
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-4/#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="463" height="110" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/16024751/Screenshot-2025-07-16-121735.png" alt="" class="wp-image-987194" style="width:920px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/16024751/Screenshot-2025-07-16-121735.png 463w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/16024751/Screenshot-2025-07-16-121735-300x71.png 300w" sizes="(max-width: 463px) 100vw, 463px" /></a></figure>
Read Next: 
<ul class="wp-block-list">
<li><a href="https://benzinga.com/markets/equities/25/07/46435021/nuwellis-soars-31-25-in-after-hours-trading-whats-behind-the-surge">Nuwellis Soars 31.25% In After-Hours Trading — What&#8217;s Behind The Surge?</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo Courtesy: Shutterstock/iQoncept

Biotech

Equities

Events

Market-Moving Exclusives

Signals

Pre-Market Outlook

Markets

General

PLRZ

Polyrizon Stock Slides After Hours After 52% Surge On Tuesday: Why It Moved

President&nbsp;Donald Trump&nbsp;said Tuesday he has secured the commitment of House Republicans to vote in favor of the GENIUS Act after procedural failures halted its progress earlier in the day.
What Happened:&nbsp;In a Truth Social <a href="https://truthsocial.com/@realDonaldTrump/posts/114860136006223294">post</a>, Trump said that he had secured the support of 11 out of the 12 necessary Congress members&nbsp;to pass the GENIUS Act, also known as the stablecoin bill. The decision was reached during a meeting in the Oval Office, with&nbsp;Speaker of the House Mike Johnson&nbsp;(R-La.) participating via telephone. 
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="737" height="447" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/16030932/image-189.png" alt="" class="wp-image-987243" style="width:470px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/16030932/image-189.png 737w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/16030932/image-189-300x182.png 300w" sizes="(max-width: 737px) 100vw, 737px" /></figure>
&#8220;After a short discussion, they have all agreed to vote tomorrow morning in favor of the Rule,&#8221; Trump said. &#8220;I want to thank the Congressmen/women for their quick and positive response.&#8221;
Republicans, including Rep.&nbsp;Marjorie Taylor Greene&nbsp;(R-Ga.), had opposed the Act earlier due to a lack of a clause prohibiting Central Bank Digital Currency and the Speaker&#8217;s refusal to consider amendments.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">I just voted NO on the Rule for the GENIUS Act because it does not include a ban on Central Bank Digital Currency and because Speaker Johnson did not allow us to submit amendments to the GENIUS Act. Americans do not want a government-controlled Central Bank Digital Currency.… <a href="https://t.co/NnkeIOH0dE">pic.twitter.com/NnkeIOH0dE</a>
&mdash; Rep. Marjorie Taylor Greene&#x1f1fa;&#x1f1f8; (@RepMTG) <a href="https://twitter.com/RepMTG/status/1945195703292092555?ref_src=twsrc%5Etfw">July 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The GENIUS Act has received a lot of attention, especially since it <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45989307/senate-passes-genius-act-coinbases-brian-armstrong-calls-it-big-milestone-scott-bessent-says-passage-could-drive-stablecoins-into-a-3-7-trillion-market">passed the Senate</a> last month. 
Earlier, Trump&nbsp;wished everyone a&nbsp;&#8220;Happy Crypto Week"&nbsp;and urged all Republicans to support the GENIUS Act to make the U.S. the undisputed leader in digital assets. However, the <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46433854/trumps-happy-crypto-week-gets-off-to-rocky-start-as-house-suspends-votes-on-key-bills">procedural vote needed</a> to advance key cryptocurrency bills failed, resulting in the suspension of further votes.
Photo courtesy: Maxim Elramsisy / Shutterstock.com
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46392541/how-donald-trumps-big-beautiful-bill-was-a-big-beautiful-boost-for-bitcoin" target="_blank" rel="noreferrer noopener">How Donald Trump's ‘Big Beautiful Bill' Was A ‘Big Beautiful Boost' For Bitcoin</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" rel="noreferrer noopener" target="_blank"></a>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Trump Says 11 Of 12 Republicans Needed Now Support Stablecoin Bill After Earlier Setback — They've All Agreed To Vote In Favor

As the Donald Trump administration plans up to 200% tariffs on pharmaceutical companies, Emily Field, head of European pharma research at Barclays, has said that it&#8217;s hard to predict which firm would be affected the most by these tariffs, except for Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>).
Check out the current price of&nbsp;<a href="https://www.benzinga.com/quote/NVO">NVO stock here</a>.
What Happened: Explaining that the pharmaceutical companies as a whole are &#8220;out of favor&#8221; for tariffs, Field <a href="https://www.cnbc.com/video/2025/07/14/barclays-the-pharma-sector-is-very-out-of-favor-for-tariffs.html">told</a> CNBC that it was hard to single out a company that could be the most affected by the levies.
&#8220;It&#8217;s really difficult to say because they have really complex supply chains and companies like to keep it under the wraps,&#8221; she said, adding that &#8220;Novo Nordisk has been called out just because we know a lot of active pharmaceutical ingredients for Wegovy are manufactured in Denmark, so that&#8217;s just one that investors have highlighted.&#8221;
She adds, &#8220;But that could also just be because we have a more concrete idea of how their drug flows. But for the most part, this sector is just very out of favor for tariffs.&#8221;
Talking about the European pharma companies that were planning to invest in the U.S., Field mentioned Novartis AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>), Roche Holdings AG (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/RHHBY#OTCQX">RHHBY</a>), and AstraZeneca PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZN#NASDAQ">AZN</a>).
&#8220;We have seen from a number of European companies very significant announcements about manufacturing investments in the United States. We have seen that from Novartis, Roche, and we also know that the companies are working with the administration on this &#8216;Most Favored Nation&#8217; (MFN) drug pricing policy,&#8221; she said.
She also added that AstraZeneca is likely considering changing its registration to the U.S. &#8220;All of the companies based in Europe are emphasizing that they are very committed to the U.S. and manufacturing in the U.S.&#8221;
According to Field, this is all connected in some way. &#8220;It could be a combination of tariffs and drug pricing that the industry and administration can strike a deal that is favorable to both parties,&#8221; Field explained.
See Also: <a href="https://www.benzinga.com/markets/tech/25/07/46400448/dan-ives-bets-on-cybersecurity-as-biggest-subsector-in-tech-for-2025-expects-strong-q2-earnings-from-crowdstrike-zscaler-palo-alto-check-point">Dan Ives Bets On Cybersecurity As &#8216;Biggest Subsector&#8217; In Tech For 2025; Expects Strong Q2 Earnings From CrowdStrike, Zscaler, Palo Alto, Check Point</a>
Why It Matters: Barclays has also <a href="https://www.benzinga.com/markets/equities/25/07/46364024/trump-threatens-200-pharma-tariffs-but-analyst-says-this-stock-is-immune-and-expected-to-benefit-from-levies">cautioned that a 200% pharma tariff</a> would &#8220;inflate production costs, compress profit margins, and risk supply chain disruptions." 
&#8220;We are waiting for the results of the Section 232 investigation from the Commerce Ministry, which is supposed to come by the end of the month. Prior to Trump saying that he was going to announce 200%, I think most have been expecting 25%; however, the industry&#8217;s response is that tariffs will be negative for patients, as it could result in drug shortages,&#8221; Feild said.
These are some pharma ETFs that could be impacted as the long-awaited industry-wide tariffs would be announced &#8220;very soon,&#8221; according to Trump.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Pharma ETFs</td>
<td>YTD Performance</td>
<td>One-Year Performance</td>
</tr>
<tr>
<td>VanEck Pharmaceutical ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPH#NASDAQ">PPH</a>)</td>
<td>0.45%</td>
<td>-6.90%</td>
</tr>
<tr>
<td>iShares US Pharmaceuticals ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IHE#NYSE">IHE</a>)</td>
<td>1.01%</td>
<td>-3.91%</td>
</tr>
<tr>
<td>Invesco Pharmaceuticals ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PJP#NYSE">PJP</a>)</td>
<td>-1.22%</td>
<td>-3.19%</td>
</tr>
<tr>
<td>SPDR S&amp;P Pharmaceuticals ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPH#NYSE">XPH</a>)</td>
<td>-1.95%</td>
<td>-1.55%</td>
</tr>
<tr>
<td>KraneShares MSCI All China Health Care Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KURE#NYSE">KURE</a>)</td>
<td>29.34%</td>
<td>33.78%</td>
</tr>
<tr>
<td>First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTXH#NASDAQ">FTXH</a>)</td>
<td>-3.88%</td>
<td>-8.36%</td>
</tr>
<tr>
<td>Direxion Daily Pharmaceutical &amp; Medical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PILL#NYSE">PILL</a>)</td>
<td>-18.59%</td>
<td>-24.16%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, ended mixed on Tuesday. The SPY was down 0.43% at $622.14, while the QQQ advanced 0.092% to $556.72, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pr</a>o data.
On Wednesday, the futures of the S&amp;P 500, Dow Jones, and Nasdaq 100 indices were trading lower.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/hedge-funds/25/07/46386374/stanley-druckenmillers-duquesne-dumps-palantir-bets-big-on-this-dividend-play-which-has-surged-nearly-50-in-2025">Stanley Druckenmiller&#8217;s Duquesne Dumps Palantir, Bets Big On This Dividend Play Which Has Surged Nearly 50% In 2025</a></li>
</ul>
Photo courtesy: JHVEPhoto / Shutterstock.com

FTXH

iShares Dow Jones US Pharmaceuticals Index Fund

KURE

PILL

Merrill Lynch Pharmaceutical HOLDRs Trust

RHHBY

Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains'

ANTA

GLXY

Backed By Galaxy Digital And Antalpha, Function Launches FBTC With $1.5B In TVL To Transform Bitcoin Into A Productive Financial Asset

IPOs

MGRT

Reported Earlier, Mega Fortune Prices $15M Initial Public Offering Of 3.75M Common Shares At $4.00 Per Share

ZJYL

Reported Earlier, Jin Medical Launches Production At Plant No. 3 In Chuzhou To Accelerate Global Delivery Of High-Precision Rehabilitation Devices

Fiscal Year 2025 Financial Summary
<ul>
<li>Net revenues were $25.4 million in fiscal year 2025, compared to $32.2 million in fiscal year 2024.</li>
<li>Gross profit was $10.5 million in fiscal year 2025, compared to $13.1 million in fiscal year 2024.</li>
<li>Gross margin was 41.1% in fiscal year 2025, increased from 40.7% in fiscal year 2024.</li>
<li>Net Loss was $5.3 million in fiscal year 2025, compared to net income of $1.9 million in fiscal year 2024.</li>
<li>Basic and diluted losses per share were $1.10 in fiscal year 2025, compared to basic and diluted earnings per share of $0.43 in fiscal year 2024.</li>
</ul>

FLYE

Reported Earlier, Fly-E Group FY2025 EPS $(1.10) Down From $0.43 YoY, Revenue $25.427M Down From $32.205M YoY

Elon Musk&#8216;s strategy to leverage resources across his business empire, including&nbsp;Tesla Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), SpaceX, and xAI, has sparked investor concerns, particularly after a recent controversy involving chatbot Grok.
What Happened: Musk is promoting a &#8216;Muskonomy&#8217; strategy that would allow investors to invest in his various businesses, which include SpaceX, X, xAI, and The Boring Company, <a href="https://www.businessinsider.com/elon-musk-north-star-ai-tesla-xai-spacex-investments-2025-7">reported</a> Business Insider. He has even promised to prioritize &#8220;longtime shareholders&#8221; if any of his companies go public. This strategy could potentially help Tesla meet its AI demands for autonomous driving by leveraging resources across Musk&#8217;s other companies.
Check out the current price of&nbsp;<a href="https://benzinga.com/quote/aapl" target="_blank" rel="noreferrer noopener">TSLA stock here</a>.
However, this strategy carries notable risks. For example, Grok's recent controversy over anti-Semitic content on X has raised alarms about incorporating the chatbot into Tesla's electric vehicles. Additionally, Musk's move last year to redirect a $500 million shipment of Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) chips—originally meant for Tesla—to X and xAI triggered concern among investors. Musk defended the move, saying it was beneficial for Tesla as the company lacked the infrastructure to utilize the chips at the time.
Analyst Gadjo Sevilla from EMARKETER, expressed concern about Musk&#8217;s strategy of &#8220;cannibalizing one business to prop&nbsp;up another one could take its toll.&#8221; This could potentially delay innovation at Tesla, warned the analyst.
Meanwhile, Garrett Nelson, senior VP and equity analyst at CFRA Research, pointed out that other companies usually conduct the interplay under &#8220;one corporate umbrella.&#8221; However, with Musk, &#8220;the relationship and interplay between his private companies and a public company (Tesla)&#8221; is the key distinguishing factor.
See Also:&nbsp;<a href="https://benzinga.com/crypto/cryptocurrency/25/07/46429234/bitcoin-xrp-dogecoin-dip-but-ethereum-outperforms-after-inflation-report" target="_blank" rel="noreferrer noopener">Bitcoin, XRP, Dogecoin Dip But Ethereum Outperforms After Inflation Report &#8211; Benzinga</a>
Why It Matters: Musk&#8217;s &#8216;Muskonomy&#8217; strategy comes at a crucial time for Tesla, which is currently facing an <a href="https://www.benzinga.com/markets/tech/25/07/46392190/tesla-identity-crisis-musks-xai-vote-could-rewrite-the-ev-makers-dna">identity crisis</a>. Musk recently announced that Tesla shareholders would vote on a potential investment in his AI venture, xAI, raising questions about whether Tesla is evolving into an AI-fueled tech conglomerate. 
While veteran investor Gary Black suggested that a shareholder vote would be the fairest way to decide on a potential merger between Tesla and xAI, some are questioning Musk&#8217;s plans to sell xAI.
Musk has been vocal about his desire for Tesla to invest in xAI, but has left the final decision to the shareholders. Despite the potential risks, some analysts believe that xAI is worth the bet, as it could significantly benefit Tesla&#8217;s AI ambitions.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="773" height="120" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/16024150/image-187.png" alt="" class="wp-image-987176" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/16024150/image-187.png 773w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/16024150/image-187-300x47.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/16024150/image-187-768x119.png 768w" sizes="(max-width: 773px) 100vw, 773px" /></figure>
Benzinga's Edge Rankings place Tesla in the 50th percentile for quality and the 91st percentile for growth, reflecting mixed performance. Check the detailed report <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">here</a>.&nbsp;
READ MORE: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46434613/elon-musks-tesla-could-face-stricter-oversight-as-trumps-nhtsa-pick-targets-autonomous-driving-cannot-sit-back">Elon Musk&#8217;s Tesla Could Face Stricter Oversight As Trump&#8217;s NHTSA Pick Targets Autonomous Driving: &#8216;Cannot Sit Back&#8217; </a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

TSLA

Elon Musk's 'Muskonomy' Strategy Could Take A 'Toll' On Tesla, Potentially Delaying Innovation, Warn Experts

today announced the pricing of a public offering of an aggregate of 9,090,909 shares of its common stock (or pre-funded warrants in lieu thereof), Series A warrants to purchase 9,090,909 shares of its common stock and Series B warrants to purchase 9,090,909 shares of its common stock, at a combined public offering price of $0.55 per share (or pre-funded warrant in lieu thereof) and accompanying warrants. Each of the Series A warrants and the Series B warrants will have an exercise price of $0.55 per share and will be exercisable immediately upon issuance.&nbsp;

SLNH

Reported Earlier, Soluna Holdings Prices $5M Common Stock And Warrant Offering At $0.55 Per Unit

Reported Earlier, LiveOne Launches Proposed Public Offering Of Common Stock

<ul>
<li>Expected to Generate ~$470 million in Net Proceeds, Reflecting Strong Equity Appreciation</li>
<li>Newmont Remains on Track to Deliver on its 2025 Guidance and Capital Allocation Priorities</li>
</ul>

Reported Earlier, Newmont Monetizes Equity From Greatland And Discovery Stakes With ~230% And ~200% Returns, Generating ~$470M In Net Proceeds

Reported Earlier, AECOM Prices $1.2B Of Senior Unsecured Notes Due 2033 With 6.0% Coupon To Support Tender Offer And Redemption Of 2027 Notes

TTGT

Reported Earlier, TechTarget Restores Compliance With Nasdaq Listing Rules Following July 14 Filing Of Q1 2025 Form 10-Q

HBAN

VBTX

Reported Earlier, Veritex Holdings Reschedules Q2 2025 Earnings Release To July 18 And Cancels Conference Call Following Acquisition Agreement With Huntington Bancshares

Comments

Empro Group

Empro Group (EMPG) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL